“…Our model established that macrophages promoted the progression of metaplasia, but is not required for metaplasia induction. Efforts to circumvent metaplasia development through manipulation of EGF ligands/receptors (Areg [34], EGFR [34, 35]), endocrine pathways (gastrin [10, 36], histamine [37]) and cytokines (IFNγ [38, 39, 40], IL–11 [41]) have yet to identify factor(s) necessary for the induction of metaplasia in response to parietal cell loss in either an acute drug induced system or chronic Helicobacter infection. Previous studies found that administration of IL-33 is sufficient to induce hypertrophy and mucous metaplasia in the airway, stomach, and intestine through the induction Th2 cytokines and infiltration of myeloid cells and eosinophils [20, 21, 42, 43, 44, 45].…”